St. Jude Medical (STJ) Shares are Up 1.04%

St. Jude Medical (STJ) : Traders are bullish on St. Jude Medical (STJ) as it has outperformed the S&P 500 by a wide margin of 1.59% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 0.61%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 1.04% in the last 1 week, and is up 4.12% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.

St. Jude Medical (NYSE:STJ): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $83.47 and $83.44 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $83.94. The buying momentum continued till the end and the stock did not give up its gains. It closed at $83.90, notching a gain of 0.54% for the day. The total traded volume was 1,032,576 . The stock had closed at $83.45 on the previous day.

The stock has recorded a 20-day Moving Average of 2.6% and the 50-Day Moving Average is 5.97%. St. Jude Medical Inc. is up 12.17% in the last 3-month period. Year-to-Date the stock performance stands at 37.16%.

St. Jude Medical (STJ) : Currently there are 16 street experts covering St. Jude Medical (STJ) stock. The most bullish and bearish price target for the stock is $89 and $54 respectively for the short term. The average price target of all the analysts comes to $76.09. The estimated standard deviation from the target is $12.01.


St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Its six principal product categories include tachycardia implantable cardioverter defibrillator (ICD) systems, bradycardia pacemaker systems, atrial fibrillation (AF) products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems), vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, heart failure monitoring device and other vascular accessories), structural heart products and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation to treat movement disorders).

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.